nach oben

Irish Journal of Medical Science (1971 -)

Erschienen in:

01.09.2009 | Original Article

The value of appropriate assessment prior to specialist referral in men with prostatic symptoms

verfasst von: M. R. Quinlan, B. J. O’Daly, M. F. O’Brien, S. Gardner, G. Lennon, D. W. Mulvin, D. M. Quinlan

Erschienen in: Irish Journal of Medical Science (1971 -) | Ausgabe 3/2009

Einloggen, um Zugang zu erhalten

Abstract

Background

Referrals to Urology OPD of men with a likely diagnosis of BPH are common.

Aims

To review referrals to OPD of men with lower urinary tract symptoms (LUTS) to establish how many could have been managed without specialist assessment.

Methods

We reviewed records of 200 male patients referred to OPD with LUTS. We assessed whether the referral source had performed digital rectal examination (DRE), International Prostate Symptom Score (IPSS), Bother Score or PSA level.

Results

74% of patients were referred by GPs. In 31.5% of cases DRE was performed prior to referral. One GP had completed an IPSS, none a Bother Score. 96% had a PSA checked before OPD. Ultimately, 88.5% of our patients were diagnosed with BPH.

Conclusions

With better pre-assessment in the form of DRE, IPSS and Bother Score, allied to a PSA check, many patients with LUTS could be managed in a primary care setting.

Wei JT, Calhoun E, Jacobsen SJ (2005) Urologic diseases in America project: benign prostatic hyperplasia. J Urol 173(4):1256–1261. doi:10.1097/01.ju.0000155709.37840.fe PubMedCrossRef

Walsh PC (2002) Surgery and the reduction of mortality from prostate cancer. N Engl J Med 347(11):839–840. doi:10.1056/NEJMe020089 PubMedCrossRef

Hamilton W, Sharp D (2004) Symptomatic diagnosis of prostate cancer in primary care: a structured review. Br J Gen Pract 54(505):617–621PubMed

Thompson IM, Ankerst DP, Chi C et al (2006) Assessing prostate cancer risk: results from the prostate cancer prevention trial. J Natl Cancer Inst 98(8):529–534PubMed

Babaian RJ, Miyashita H, Evans RB, von Eschenbach AC, Ramirez EI (1991) Early detection program for prostate cancer: results and identification of high-risk patient population. Urology 37(3):193–197. doi:10.1016/0090-4295(91)80283-D PubMedCrossRef

Irani J, Brown CT, van der Meulen J, Emberton M (2003) A review of guidelines on benign prostatic hyperplasia and lower urinary tract symptoms: are all guidelines the same? BJU Int 92(9):937–942. doi:10.1111/j.1464-410X.2003.04529.x PubMedCrossRef

Barry MJ, Fowler FJ Jr, O’Leary MP et al (1992) The American Urological Association symptom index for benign prostatic hyperplasia, The Measurement Committee of the American Urological Association. J Urol 148(5):1549–1557 (discussion 1564)PubMed

O’Leary MP (2005) Validity of the “bother score” in the evaluation and treatment of symptomatic benign prostatic hyperplasia. Rev Urol 7(1):1–10PubMed

Jepsen JV, Bruskewitz RC (1998) Comprehensive patient evaluation for benign prostatic hyperplasia. Urology 51(4A Suppl):13–18PubMedCrossRef

10.

Carballido Rodriguez J, Badia Llach X, Gimeno Collado A, Regadera Anechina L, Dal-Re Saavedra R, Guilera Sarda M (2006) Validity of tests for initial diagnosis and its concordance with final diagnosis in patients with suspected benign prostatic hyperplasia. Actas Urol Esp 30(7):667–674PubMedCrossRef

11.

Fawzy A, Fontenot C, Guthrie R, Baudier MM (1997) Practice patterns among primary care physicians in benign prostatic hyperplasia and prostate cancer. Fam Med 29(5):321–325PubMed

12.

Quinlan MR, Teahan S, Mulvin D, Quinlan DM (2007) Is digital rectal examination still necessary in the early detection of prostate cancer? Ir J Med Sci 176(3). doi:10.1007/s11845-007-0018-x

13.

Pedersen KV, Carlsson P, Varenhorst E, Lofman O, Berglund K (1990) Screening for carcinoma of the prostate by digital rectal examination in a randomly selected population. BMJ 300(6731):1041–1044PubMedCrossRef

14.

Kirby RS, Kirby MG, Feneley MR, McNicholas T, McLean A, Webb JA (1994) Screening for carcinoma of the prostate: a GP based study. Br J Urol 74(1):64–71. doi:10.1111/j.1464-410X.1994.tb16549.x PubMedCrossRef

15.

Casey RG, Quinlan MR, Flynn R, Grainger R, McDermott TE, Thornhill JA (2007) Urology out-patient non-attenders: are we wasting our time? Ir J Med Sci 176(4):305–308. doi:10.1007/s11845-007-0028-8 PubMedCrossRef

16.

Bosch JL, Bohnen AM, Groeneveld FP (2004) Validity of digital rectal examination and serum prostate specific antigen in the estimation of prostate volume in community-based men aged 50 to 78 years: the Krimpen Study. Eur Urol 46(6):753–759. doi:10.1016/j.eururo.2004.07.019 PubMedCrossRef

17.

Roehrborn CG, Girman CJ, Rhodes T et al (1997) Correlation between prostate size estimated by digital rectal examination and measured by transrectal ultrasound. Urology 49(4):548–557. doi:10.1016/S0090-4295(97)00031-9 PubMedCrossRef

18.

Kaplan SA, Olsson CA, Te AE (1996) The American Urological Association symptom score in the evaluation of men with lower urinary tract symptoms: at 2 years of followup, does it work? J Urol 155(6):1971–1974. doi:10.1016/S0022-5347(01)66064-6 PubMedCrossRef

19.

Flam T, Montauban V (2003) Screening of clinical benign prostatic hypertrophy in general practice: survey of 18, 540 men. Prog Urol 13(3):416–424PubMed

20.

McGuire BB, O’Brien MF, McLoughlin S, O’Malley KJ, Fitzpatrick JM (2007) Should patients with symptomatic BPH have a trial of medical therapy by their general practitioner prior to referral for urological assessment? Ir Med J 100(4):428–429PubMed

21.

Samaritan G, Pearlman RA (2007) Underdiagnosed and undertreated colorectal cancer tops liability list. J Med Assoc Ga 96(1):48PubMed

22.

Verhamme KM, Dieleman JP, Bleumink GS et al (2002) Incidence and prevalence of lower urinary tract symptoms suggestive of benign prostatic hyperplasia in primary care–the Triumph project. Eur Urol 42(4):323–328. doi:10.1016/S0302-2838(02)00354-8 PubMedCrossRef

23.

Bruskewitz R (1999) Management of symptomatic BPH in the US: who is treated and how? Eur Urol 36(Suppl 3):7–13. doi:10.1159/000052343 PubMedCrossRef

24.

McNicholas TA (1999) Management of symptomatic BPH in the UK: who is treated and how? Eur Urol 36(Suppl 3):33–39. doi:10.1159/000052347 PubMedCrossRef

Titel: The value of appropriate assessment prior to specialist referral in men with prostatic symptoms
verfasst von: M. R. Quinlan
B. J. O’Daly
M. F. O’Brien
S. Gardner
G. Lennon
D. W. Mulvin
D. M. Quinlan
Publikationsdatum: 01.09.2009
Verlag: Springer-Verlag
Erschienen in: Irish Journal of Medical Science (1971 -) / Ausgabe 3/2009
Print ISSN: 0021-1265
Elektronische ISSN: 1863-4362
DOI: https://doi.org/10.1007/s11845-009-0337-1

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Schadet Ärger den Gefäßen?

14.05.2024 Arteriosklerose Nachrichten

In einer Studie aus New York wirkte sich Ärger kurzfristig deutlich negativ auf die Endothelfunktion gesunder Probanden aus. Möglicherweise hat dies Einfluss auf die kardiovaskuläre Gesundheit.

Intervallfasten zur Regeneration des Herzmuskels?

14.05.2024 Herzinfarkt Nachrichten

Die Nahrungsaufnahme auf wenige Stunden am Tag zu beschränken, hat möglicherweise einen günstigen Einfluss auf die Prognose nach akutem ST-Hebungsinfarkt. Darauf deutet eine Studie an der Uniklinik in Halle an der Saale hin.

Klimaschutz beginnt bei der Wahl des Inhalators

14.05.2024 Klimawandel Podcast

Auch kleine Entscheidungen im Alltag einer Praxis können einen großen Beitrag zum Klimaschutz leisten. Die neue Leitlinie zur "klimabewussten Verordnung von Inhalativa" geht mit gutem Beispiel voran, denn der Wechsel vom klimaschädlichen Dosieraerosol zum Pulverinhalator spart viele Tonnen CO₂. Leitlinienautor PD Dr. Guido Schmiemann erklärt, warum nicht nur die Umwelt, sondern auch Patientinnen und Patienten davon profitieren.

Typ-2-Diabetes und Depression folgen oft aufeinander

14.05.2024 Typ-2-Diabetes Nachrichten

Menschen mit Typ-2-Diabetes sind überdurchschnittlich gefährdet, in den nächsten Jahren auch noch eine Depression zu entwickeln – und umgekehrt. Besonders ausgeprägt ist die Wechselbeziehung laut GKV-Daten bei jüngeren Erwachsenen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Background

Aims

Methods

Results

Conclusions

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2009

A review of repeat prostate biopsies and the influence of technique on cancer detection: our experience

Imported childhood malaria: the Dublin experience, 1999–2006

Management of refractory venous thrombosis associated with malignancy using a supra-therapeutic enoxaparin regimen

Spontaneous rapid resolution of acute subdural hematoma after head trauma: Is it truly rare?

Doctors’ attitudes about prescribing and knowledge of the costs of common medications

Evaluation of carboplatin dosage based on 4-variable modification of diet in renal disease equation